0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bipolar Disorder Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-9F6339
Home | Market Reports | Health| Mental Health| Depression
Global Bipolar Disorder Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bipolar Disorder Market Research Report 2024

Code: QYRE-Auto-9F6339
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bipolar Disorder Market Size

The global Bipolar Disorder market was valued at US$ 5781 million in 2023 and is anticipated to reach US$ 6994.7 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.

Bipolar Disorder Market

Bipolar Disorder Market

Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.
North American market for Bipolar Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bipolar Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Bipolar Disorder in Mood Stabilizers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Bipolar Disorder include Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder.

Report Scope

The Bipolar Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bipolar Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bipolar Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bipolar Disorder Market Report

Report Metric Details
Report Name Bipolar Disorder Market
Accounted market size in 2023 US$ 5781 million
Forecasted market size in 2030 US$ 6994.7 million
CAGR 2.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Bipolar I Disorder
  • Bipolar II Disorder
  • Cyclothymic Disorder
Segment by Application
  • Mood Stabilizers
  • Anticonvulsants
  • Antipsychotic drugs
  • Antidepressant drugs
  • Antianxiety drugs
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bipolar Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bipolar Disorder Market growing?

Ans: The Bipolar Disorder Market witnessing a CAGR of 2.7% during the forecast period 2024-2030.

What is the Bipolar Disorder Market size in 2030?

Ans: The Bipolar Disorder Market size in 2030 will be US$ 6994.7 million.

Who are the main players in the Bipolar Disorder Market report?

Ans: The main players in the Bipolar Disorder Market are Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd, AstraZeneca

What are the Application segmentation covered in the Bipolar Disorder Market report?

Ans: The Applications covered in the Bipolar Disorder Market report are Mood Stabilizers, Anticonvulsants, Antipsychotic drugs, Antidepressant drugs, Antianxiety drugs, Others

What are the Type segmentation covered in the Bipolar Disorder Market report?

Ans: The Types covered in the Bipolar Disorder Market report are Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bipolar I Disorder
1.2.3 Bipolar II Disorder
1.2.4 Cyclothymic Disorder
1.3 Market by Application
1.3.1 Global Bipolar Disorder Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2019-2030)
2.2 Bipolar Disorder Growth Trends by Region
2.2.1 Global Bipolar Disorder Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bipolar Disorder Historic Market Size by Region (2019-2024)
2.2.3 Bipolar Disorder Forecasted Market Size by Region (2025-2030)
2.3 Bipolar Disorder Market Dynamics
2.3.1 Bipolar Disorder Industry Trends
2.3.2 Bipolar Disorder Market Drivers
2.3.3 Bipolar Disorder Market Challenges
2.3.4 Bipolar Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Revenue
3.1.1 Global Top Bipolar Disorder Players by Revenue (2019-2024)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2023
3.5 Bipolar Disorder Key Players Head office and Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Breakdown Data by Type
4.1 Global Bipolar Disorder Historic Market Size by Type (2019-2024)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2025-2030)
5 Bipolar Disorder Breakdown Data by Application
5.1 Global Bipolar Disorder Historic Market Size by Application (2019-2024)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bipolar Disorder Market Size (2019-2030)
6.2 North America Bipolar Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bipolar Disorder Market Size by Country (2019-2024)
6.4 North America Bipolar Disorder Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bipolar Disorder Market Size (2019-2030)
7.2 Europe Bipolar Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bipolar Disorder Market Size by Country (2019-2024)
7.4 Europe Bipolar Disorder Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorder Market Size (2019-2030)
8.2 Asia-Pacific Bipolar Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bipolar Disorder Market Size by Region (2019-2024)
8.4 Asia-Pacific Bipolar Disorder Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bipolar Disorder Market Size (2019-2030)
9.2 Latin America Bipolar Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bipolar Disorder Market Size by Country (2019-2024)
9.4 Latin America Bipolar Disorder Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorder Market Size (2019-2030)
10.2 Middle East & Africa Bipolar Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bipolar Disorder Market Size by Country (2019-2024)
10.4 Middle East & Africa Bipolar Disorder Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Detail
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2019-2024)
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2019-2024)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2019-2024)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Detail
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2019-2024)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2019-2024)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Detail
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2019-2024)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Detail
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2019-2024)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2019-2024)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Bipolar Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Bipolar I Disorder
    Table 3. Key Players of Bipolar II Disorder
    Table 4. Key Players of Cyclothymic Disorder
    Table 5. Global Bipolar Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Bipolar Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Bipolar Disorder Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Bipolar Disorder Market Share by Region (2019-2024)
    Table 9. Global Bipolar Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Bipolar Disorder Market Share by Region (2025-2030)
    Table 11. Bipolar Disorder Market Trends
    Table 12. Bipolar Disorder Market Drivers
    Table 13. Bipolar Disorder Market Challenges
    Table 14. Bipolar Disorder Market Restraints
    Table 15. Global Bipolar Disorder Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Bipolar Disorder Market Share by Players (2019-2024)
    Table 17. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2023)
    Table 18. Ranking of Global Top Bipolar Disorder Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Bipolar Disorder Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Bipolar Disorder Product Solution and Service
    Table 22. Date of Enter into Bipolar Disorder Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Bipolar Disorder Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Bipolar Disorder Revenue Market Share by Type (2019-2024)
    Table 26. Global Bipolar Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Bipolar Disorder Revenue Market Share by Type (2025-2030)
    Table 28. Global Bipolar Disorder Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Bipolar Disorder Revenue Market Share by Application (2019-2024)
    Table 30. Global Bipolar Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Bipolar Disorder Revenue Market Share by Application (2025-2030)
    Table 32. North America Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Bipolar Disorder Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Bipolar Disorder Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Bipolar Disorder Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Bipolar Disorder Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Bipolar Disorder Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Bipolar Disorder Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Bipolar Disorder Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Bipolar Disorder Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Bipolar Disorder Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Bipolar Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Bipolar Disorder Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Bipolar Disorder Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Glaxo SmithKline (GSK) Company Detail
    Table 48. Glaxo SmithKline (GSK) Business Overview
    Table 49. Glaxo SmithKline (GSK) Bipolar Disorder Product
    Table 50. Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 51. Glaxo SmithKline (GSK) Recent Development
    Table 52. Pfizer Inc. Company Detail
    Table 53. Pfizer Inc. Business Overview
    Table 54. Pfizer Inc. Bipolar Disorder Product
    Table 55. Pfizer Inc. Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 56. Pfizer Inc. Recent Development
    Table 57. Janssen Pharmaceuticals Company Detail
    Table 58. Janssen Pharmaceuticals Business Overview
    Table 59. Janssen Pharmaceuticals Bipolar Disorder Product
    Table 60. Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 61. Janssen Pharmaceuticals Recent Development
    Table 62. Eli Lilly Company Detail
    Table 63. Eli Lilly Business Overview
    Table 64. Eli Lilly Bipolar Disorder Product
    Table 65. Eli Lilly Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 66. Eli Lilly Recent Development
    Table 67. Allergan Plc. Company Detail
    Table 68. Allergan Plc. Business Overview
    Table 69. Allergan Plc. Bipolar Disorder Product
    Table 70. Allergan Plc. Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 71. Allergan Plc. Recent Development
    Table 72. Novartis AG Company Detail
    Table 73. Novartis AG Business Overview
    Table 74. Novartis AG Bipolar Disorder Product
    Table 75. Novartis AG Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 76. Novartis AG Recent Development
    Table 77. AbbVie Inc. Company Detail
    Table 78. AbbVie Inc. Business Overview
    Table 79. AbbVie Inc. Bipolar Disorder Product
    Table 80. AbbVie Inc. Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 81. AbbVie Inc. Recent Development
    Table 82. Otsuka Holdings Ltd Company Detail
    Table 83. Otsuka Holdings Ltd Business Overview
    Table 84. Otsuka Holdings Ltd Bipolar Disorder Product
    Table 85. Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 86. Otsuka Holdings Ltd Recent Development
    Table 87. AstraZeneca Company Detail
    Table 88. AstraZeneca Business Overview
    Table 89. AstraZeneca Bipolar Disorder Product
    Table 90. AstraZeneca Revenue in Bipolar Disorder Business (2019-2024) & (US$ Million)
    Table 91. AstraZeneca Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bipolar Disorder Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Bipolar Disorder Market Share by Type: 2023 VS 2030
    Figure 3. Bipolar I Disorder Features
    Figure 4. Bipolar II Disorder Features
    Figure 5. Cyclothymic Disorder Features
    Figure 6. Global Bipolar Disorder Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Bipolar Disorder Market Share by Application: 2023 VS 2030
    Figure 8. Mood Stabilizers Case Studies
    Figure 9. Anticonvulsants Case Studies
    Figure 10. Antipsychotic drugs Case Studies
    Figure 11. Antidepressant drugs Case Studies
    Figure 12. Antianxiety drugs Case Studies
    Figure 13. Others Case Studies
    Figure 14. Bipolar Disorder Report Years Considered
    Figure 15. Global Bipolar Disorder Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Bipolar Disorder Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Bipolar Disorder Market Share by Region: 2023 VS 2030
    Figure 18. Global Bipolar Disorder Market Share by Players in 2023
    Figure 19. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Bipolar Disorder Revenue in 2023
    Figure 21. North America Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Bipolar Disorder Market Share by Country (2019-2030)
    Figure 23. United States Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Bipolar Disorder Market Share by Country (2019-2030)
    Figure 27. Germany Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Bipolar Disorder Market Share by Region (2019-2030)
    Figure 35. China Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Bipolar Disorder Market Share by Country (2019-2030)
    Figure 43. Mexico Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Bipolar Disorder Market Share by Country (2019-2030)
    Figure 47. Turkey Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Bipolar Disorder Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 50. Pfizer Inc. Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 51. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 52. Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 53. Allergan Plc. Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 54. Novartis AG Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 55. AbbVie Inc. Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 56. Otsuka Holdings Ltd Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 57. AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global SAD Lamp Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2L7694
Thu Feb 01 00:00:00 UTC 2024

Add to Cart

Global Touch-Based Affective Computing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30A1275
Fri Jan 26 00:00:00 UTC 2024

Add to Cart

Global Bipolar Disorder Therapeutic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22P13573
Mon Jan 22 00:00:00 UTC 2024

Add to Cart

Global Depression Treatment Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24Q15940
Thu Jan 18 00:00:00 UTC 2024

Add to Cart